Ad-hoc announcement pursuant to Article 17 of the Regulation (EU) No. 596/2024 PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchange effective upon the expiry of August 11, 2025 Gräfelfing, August 6, 2025 – The Management Board of PharmaSGP Holding SE (“PharmaSGP”) has been informed today about the decision of the man [ … ]

Ad-hoc announcement pursuant to Article 17 of the Regulation (EU) No. 596/2024 FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE Gräfelfing, July 24, 2025 – FUTRUE GmbH informed PharmaSGP Holding SE (ISIN: DE000A2P4LJ5) today that it holds more than 95% of the shares in PharmaSGP Holding SE in [ … ]

Publication of inside information in accordance with Article 17 of Regulation (EU) No. 596/2014 PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 Gräfelfing, July 11, 2025 – The Management Board of PharmaSGP Holding SE (ISIN: DE000A2P4LJ5) has today decided, based on an evaluation of current data on business development c [ … ]

Publication of inside information pursuant to Art. 17 para. 1 of Regulation (EU) 596/2014   Ad-hoc Notification PharmaSGP Holding SE: Conclusion of a delisting agreement and announcement of a delisting tender offer by FUTRUE GmbH Gräfelfing, June 10, 2025. Today, PharmaSGP Holding SE (ISIN DE000A2P4LJ5 / WKN A2P4LJ) (“PharmaSGP”) entered into a [ … ]

EQS-WpÜG: Futrue GmbH / Tender Offer Tender Offer / Target company: Pharma SGP Holding SE; Bidder: Futrue GmbH 10.06.2025 / 08:35 CET/CEST Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group. The bidder is solely responsible for the cont [ … ]